Helping Daytona Beach patients explore new treatments for relapsing multiple sclerosis through safe, expertly managed clinical studies.
We are conducting a research study to compare a new medication called remibrutinib with an existing treatment, teriflunomide, in people who have relapsing multiple sclerosis (RMS). The goal is to see how well each treatment works and how safe they are.
The study has two parts:
Core Part (up to 30 months): Participants will be randomly assigned to receive either remibrutinib or teriflunomide. Neither you nor the study team will know which treatment you are receiving during this phase. About 800 people with RMS will take part worldwide.
Extension Part (up to 5 years): After the Core Part, eligible participants can continue in the study and receive remibrutinib only. In this phase, everyone will know they are receiving the study drug.
A second, identical study will be conducted at the same time, and results from both will be combined to help researchers better understand the effects of remibrutinib.
By joining, participants receive study-related care at no cost and contribute to research that may improve future treatment options for people living with multiple sclerosis.
Ages 18 to 55
All genders welcome
Have a confirmed diagnosis of Relapsing Multiple Sclerosis (RMS)
Daytona Beach, FL
Fill out the form below to see if you qualify for our Relapsing Multiple Sclerosis study in Daytona Beach. Participation is completely voluntary, and all study-related care will be provided at no cost to you.
Why Join?
Participating in a clinical trial at Arrow Clinical Trials in Daytona Beach, is an opportunity to take charge of your health while helping advance medical science. All while under the care of experienced local physicians.
RMS is a type of MS where symptoms come and go in episodes, known as relapses, followed by periods of recovery. This study is testing a potential new treatment to help reduce relapses and slow disease progression.
We currently conduct research studies in Hypertension, Orthopedics, Cardiology, and Neurology.
Our trials include treatments for high blood pressure, joint pain, heart health, stroke recovery, migraines, and other conditions affecting the brain and nervous system.
The initial part of the study lasts up to 30 months, and participants may have the option to continue in a long-term extension study for up to 5 years.
No. All studies at Arrow Clinical Trials are provided at no cost to participants, and insurance is not required.
Any procedures, tests, or study-related care will be covered by the trial sponsor.
Yes. Participants may receive compensation for their time and travel. The exact amount depends on the study and the number of visits required.
Each study has specific requirements, such as age range, medical history, and current health status.
Our research team will review your information and conduct a screening process to determine if you qualify.